Decreased Platelet Number and Function and Increased Fibrinolysis Contribute to Postoperative Bleeding in Cardiopulmonary Bypass Patients

Summary

We simultaneously evaluated platelet and fibrinolytic parameters to assess their individual and combined contributions to postoperative blood loss in cardiopulmonary (CP) bypass patients. Platelet count, platelet aggregability, hematocrit, plasminogen (PLG) concentration, alpha₂-antiplasmin (AP) concentration, free protease activity (fPA), and antithrombin-III (AT-III) were measured in nine patients undergoing surgery using cardiopulmonary bypass. Chest tube drainage was used as the measure of postoperative blood loss. Hematocrit, platelet count, PT .G , AP and AT-TTT all decreased during CP bypass, with PLG and AT-III decreasing much more than dilution. During CP bypass, platelet aggregability to A DP did not change significantly from pre-bypass, but aggregability to arachidonic acid (AA) decreased significantly. Following protamine administration there was a large increase (83%) in fPA, the platelet count showed a further drop (from 61 % to 50% of pre-bypass levels) . and platelet aggregability decreased significantly (from 95% to 34% of prebypass levels for ADP, and from 55% to 11.9% for A A). Chest tube drainage during the first four postoperative hours correlated positively (p <0.05) with the combination of increase in free protease activity and decrease in platelet count. The total chest tube drainage correlated significantly with the combination of decrease in platelet count and the decrease in platelet aggregability. These combinations of changes correlated significantly with postoperative blood loss whereas the individual changes did not. These data indicate that during the early postoperative period the increased fibrinolytic activity and the decreased platelet count together contribute toward postoperative blood loss in CP bypass patients, and that during the entire first 24 hour period postoperatively the decreased platelet number and decreased platelet function are important contributors to blood loss.

Key words

Blood platelets - Fibrinolysis - Bleeding - Cardiopulmonary bypass

• References

• 1 Muller N, Popov-Cenic S, Buttner W, Kladetzky RG, Egli H. Studies of fibrinolytic and coagulation factors during open heart surgery. II. Postoperative bleeding tendency and changes in the coagulation system. Thromb Res 1975; 7: 589-598
• 2 Lambert CJ, Marengo-Rowe AJ, Leveson JE, Green RH, Thiele JP, Geisler GF, Adam M, Mitchel BF. The treatment of postperfusion bleeding using epsilon-aminocaproic acid, cryoprecipitate, fresh-frozen plasma, and protamine sulfate. Ann Thorac Surg 1978; 28: 440-444
• 3 Mori F, Nakahara Y, Kurata S, Furukawa S, Esato K, Mohri H. Late changes in hemostatic parameters following open heart surgery. J Cardiovasc Surg 1982; 23: 458-462
• 4 Bagge L, Lilienberg G, Nystrom SO, Tyden H. Coagulation, fibrinolysis and bleeding after open-heart surgery. Scand J Thor Cardiovasc Surg 1986; 20: 151-160
• 5 McKenzie FN, Dhall DP, Arfors KE, Nordlund S, Matheson NA. Blood platelet behaviour during and after open-heart surgery. Br Med J 1969; 2: 795-798
• 6 McKenna R, Bachmann F, Whittaker B, Gilson JR, Weinberg M. The hemostatic mechanism after open-heart surgery. II. Frequency of abnormal platelet functions during and after extracorporeal circulation. J Thorac Cardiovasc Surg 1975; 70: 298-308
• 7 Harker LA, Malpass TW, Branson HE, Flessel EA, Slichter SJ. Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: Acquired transient platelet dysfunction associated with selective alpha-granule release. Blood 1980; 56: 824-834
• 8 Mammen EF, Koets MH, Washington BC, Wolk LW, Brown JM, Burdick M, Selik NR, Wilson RF. Fiemostasis changes during cardiopulmonary bypass surgery. Sem Thromb Hemostas 1985; 11: 281-292
• 9 Mezzano D, Aranda E, Urzua J, Lema G, Habash J, Irarrazabal MJ, Pereira J. Changes in platelet beta-thromboglobulin, fibrinogen, albumin, 5-hydroxytryptamine, ATP, and ADP during and after surgery with extracorporeal circulation in man. Am J Hematol 1986; 22: 133-142
• 10 Kalter RD, Saul CM, Wetstein L, Soriano C, Reiss RF. Cardiopulmonary bypass: associated hemostatic abnormalities. J Thorac Cardiovasc Surg 1979; 77: 427-435
• 11 Soloway HB, Cornett BM, Donahoo JV, Cox SP. Differentiation of bleeding diatheses which occur following protamine correction of heparin anticoagulation. Am J Clin Path 1973; 59: 188-191
• 12 Lambert CJ, Marengo-Rowe AJ, Leveson J, Alivizatos P, Geisler GF, Adam M, Mitchel BF, Thiele JP. The tri-F titer: a rapid test for estimation of plasma fibrinogen and detection of fibrinolysis, fibrinogen) split products, and heparin. Ann Thorac Surg 1974; 18: 357-363
• 13 Kladetzky RG, Popov-Cenic S, Buttner W, Muller N, Egli H. Studies of fibrinolytic and coagulation factors during open heart surgery. I. Fibrinolytic problems during open heart surgery with ECC. Thromb Res 1975; 7: 579-588
• 14 Bick RL, Arbegast N, Crawford L, Holterman M, Adams T, Schmalhorst W. Hemostatic defects induced by cardiopulmonary bypass. Vase Surg 1975; 9: 228-243
• 15 Mammen EF. Natural proteinase inhibitors in extracorporeal circulation. Ann N Y Acad Sci 1968; 146: 754-762
• 16 Gans H, Subramanian V, John S, Castaneda AR, Lillehei CW. Theoretical and practical (clinical) considerations concerning proteolytic enzymes and their inhibitors with particular reference to changes in the plasminogen-plasmin system observed during assisted circulation in man. Ann N Y Acad Sci 1968; 146: 721-736
• 17 Gans H, Lillehei CW, Krivit W, Runyan A, MacAulay M, Gans MA. Problems in hemostasis during open-heart surgery. I. On the release of plasminogen activator. Ann Surg 1961; 154: 915-924
• 18 Stibbe J, Kluft C, Brommer EJ P, Golmes M, de Jong DS, Nauta J. Enhanced fibrinolytic activity during cardiopulmonary bypass in open-heart surgery in man is caused by extrinsic (tissue type) plasminogen activator. Eur J Clin Invest 1984; 14: 375-382
• 19 Ekert H, Montgomery D, Aberdeen E. Fibrinolysis during extracorporeal circulation: comparison of the effects of disc and membrane oxygenators. Circ Res 1971; 28: 512-517
• 20 Bachmann F, McKenna R, Cole ER, Najafi H. The hemostatic mechanism after open-heart surgery. I. Studies on plasma coagulation factors and fibrinolysis in 512 patients after extracorporeal circulation. J Thorac Cardiovasc Surg 1975; 70: 76-85
• 21 Bentall HH, Allwork SP. Fibrinolysis and bleeding in open-heart surgery. Lancet 1968; 1: 4-8
• 22 Kucuk O, Kwaan HC, Frederickson J, Wade L, Green D. Increased fibrinolytic activity in patients undergoing cardiopulmonary bypass operation. Am J Hematol 1986; 23: 223-229
• 23 Pike OM, Marquiss JE, Weiner RS, Brechenridge RT. A study of platelet counts during cardiopulmonary bypass. Transfusion 1972; 12: 119-122
• 24 Addonizio VP, Smith JB, Strauss JF, Colman RW, Edmunds LH. Thromboxane synthesis and platelet secretion during cardiopulmonary bypass with bubble oxygenator. J Thorac Cardiovasc Surg 1980; 79: 91-96
• 25 Davies GC, Sobel M, Salzman EW. Elevated plasma fibrinopeptide A and thromboxane B₂ levels during cardiopulmonary bypass. Circulation 1980; 61: 808-814
• 26 Boers M, van den Düngen JJ A M, Karliczek GF, Brenken U, van der Heide JN H, Wildevuur CR H. Two membrane oxygenators and a bubbler: a clinical comparison. Ann Thorac Surg 1983; 35: 455-462
• 27 Boonstra PW, van Imhoff GW, Eysman L, Kootstra GJ, Homan van der Heide JN, Karliczek GF, Wildevuur CR H. Reduced platelet activation and improved hemostasis after controlled cardiotomy suction during clinical membrane oxygenator perfusions. J Thorac Cardiovasc Surg 1985; 89: 900-906
• 28 Ware JA, Scott MA, Horak JK, Solis RT. Platelet aggregation during and after cardiopulmonary bypass: effect of two different cardiotomy filters. Ann Thorac Surg 1982; 34: 204-226
• 29 van den Dungen JJ A M, Karliczek GF, Brenken U, van der Heide JN H, Wildevuur CR H. Clinical study of blood trauma during perfusion with membrane and bubble oxygenators. J Thorac Cardiovasc Surg 1982; 83: 108-116
• 30 Nelson DA. Hematology and coagulation-Basic methodology. In Clinical Diagnosis and Management by Laboratory Methods Henry JB. eds. W B Saunders; Philadelphia: 1979
• 31 Born GV R. The aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927-929
• 32 Wohl RC, Sinio L, Robbins KC. Methods for studying the fibrinolytic pathway components in human plasma. Thromb Res 1982; 27: 523-535
• 33 Anderson JM, Kottke-Marchant K. Platelet interactions with biomaterials and artificial devices. CRC Crit Rev Biocompat 1985; 1: 111-204
• 34 Ramstack JM, Zuckerman L, Mockros LF. Shear-induced activation of platelets. J Biomechanics 1979; 12: 113-125
• 35 Eika C, Godak HC. Thrombocytopenia in rabbits induced by heparin, protamine, and polybrene. Scand J Haemat 1971; 8: 481-486
• 36 Eika C. On the mechanism of platelet aggregation induced by heparin, protamine, and polybrene. Scand J Haemat 1972; 9: 248-257
• 37 Ellison N, Edmunds LH, Colman RW. Platelet aggregation following heparin and protamine administration. Anesthesiology 1978; 48: 65-68
• 38 Velders AJ, Wildevuur Ch RH. Platelet damage by protamine and the protective effect of prostacyclin: an experimental study in dogs. Ann Thorac Surg 1986; 42: 168-171
• 39 Kisiel W. Human plasma protein C isolation, characterization, and mechanism of activation by alpha thrombin. J Clin Invest 1979; 64: 761-769
• 40 Sakata Y, Curriden S, Lawrence D, Griffin JH, Loskutoff DJ. Activated protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases antiactivator activity. P NAS USA 1985; 82: 1121-1125